---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-018934"
form_type: "8-K"
ticker: "CTNM"
cik: "0001855175"
company_name: "Contineum Therapeutics, Inc."
filed_at: "2024-05-31T23:59:59+00:00"
generated_at: "2026-06-01T07:15:00.140043+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Contineum Therapeutics adopts Executive Severance Plan for named executive officers

## Summary
- CEO Carmine Stengone designated Tier 1 participant; CSO Lorrain, CFO Slover designated Tier 2 participants.
- Non-CIC severance: 12 months base salary + pro-rata bonus; health coverage up to 12 months.
- CIC severance: 150% (Tier1) or 100% (Tier2) of salary+bonus; equity acceleration; health to 18/12 mo.
- Plan replaces prior severance agreements; participants must sign release and arbitration agreement.
- Plan effective May 24; participation agreements executed May 28, 2024.

## SEC filing metadata
- accession: 0001437749-24-018934
- form_type: 8-K
- ticker: CTNM
- cik: 0001855175
- company_name: Contineum Therapeutics, Inc.
- filed_at: 2024-05-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855175/000143774924018934/0001437749-24-018934-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855175/000143774924018934/cont20240524_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-018934
- JSON: https://secwatch.observer/filing/0001437749-24-018934.json
- Plain text: https://secwatch.observer/filing/0001437749-24-018934.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.